scholarly article | Q13442814 |
P50 | author | Robert A. Rosenheck | Q21094933 |
Greg Rhee | Q38799776 | ||
P2860 | cites work | Does pay-for-performance improve the quality of health care? | Q28257717 |
Systematic review: Effects, design choices, and context of pay-for-performance in health care | Q33669353 | ||
National trends in psychotropic medication polypharmacy in office-based psychiatry | Q34090959 | ||
Anticholinergic effects of medication in elderly patients. | Q34390127 | ||
Trends in Central Nervous System-Active Polypharmacy Among Older Adults Seen in Outpatient Care in the United States | Q34680769 | ||
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. | Q35700294 | ||
Prescription patterns of antidepressants: findings from a US claims database | Q37725919 | ||
Clinical Epidemiology of Single Versus Multiple Substance Use Disorders: Polysubstance Use Disorder | Q38625841 | ||
Potentially Inappropriate Antidepressant Prescriptions Among Older Adults in Office-Based Outpatient Settings: National Trends from 2002 to 2012. | Q38668808 | ||
Projected Spending on Psychotropic Medications 2013-2020. | Q38999636 | ||
Physician vs patient initiation of psychotropic prescribing in primary care settings: a content analysis of audiotapes | Q41336013 | ||
Liability associated with prescribing medications | Q42254504 | ||
Datapoints: psychotropic drug prescriptions by medical specialty | Q44749542 | ||
Increased risk among older veterans of prescribing psychotropic medication in the absence of psychiatric diagnoses | Q44907573 | ||
Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium | Q45005678 | ||
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race. | Q45048745 | ||
Prescribing of psychotropic medications to patients without a psychiatric diagnosis | Q45376777 | ||
Proportion of antidepressants prescribed without a psychiatric diagnosis is growing | Q46113035 | ||
National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. | Q46655034 | ||
Antidepressant use in the absence of common mental disorders in the general population | Q48155497 | ||
Treatment with antidepressant medications in private health plans. | Q51912615 | ||
National Prescribing Trends for High-Risk Anticholinergic Medications in Older Adults. | Q52628767 | ||
Direct-to-consumer advertising of psychotropics. An emerging and evolving form of pharmaceutical company influence | Q80275693 | ||
Unsafe Drugs Were Prescribed More Than One Hundred Million Times in the United States Before Being Recalled | Q87669762 | ||
Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015 | Q87846465 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 139-148 | |
P577 | publication date | 2018-10-17 | |
P1433 | published in | Health Services Research | Q5690687 |
P1476 | title | Initiation of new psychotropic prescriptions without a psychiatric diagnosis among US adults: Rates, correlates, and national trends from 2006 to 2015 | |
P478 | volume | 54 |
Q90609735 | Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends | cites work | P2860 |
Search more.